BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21144600)

  • 1. Repairing the parkinsonian brain with neurotrophic factors.
    Aron L; Klein R
    Trends Neurosci; 2011 Feb; 34(2):88-100. PubMed ID: 21144600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy.
    Domanskyi A; Saarma M; Airavaara M
    Hum Gene Ther; 2015 Aug; 26(8):550-9. PubMed ID: 26176331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral vector delivery of neurotrophic factors for Parkinson's disease therapy.
    Kelly MJ; O'Keeffe GW; Sullivan AM
    Expert Rev Mol Med; 2015 May; 17():e8. PubMed ID: 25997719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotrophic factor therapy for Parkinson's disease.
    Rangasamy SB; Soderstrom K; Bakay RA; Kordower JH
    Prog Brain Res; 2010; 184():237-64. PubMed ID: 20887879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease.
    Voutilainen MH; Arumäe U; Airavaara M; Saarma M
    FEBS Lett; 2015 Dec; 589(24 Pt A):3739-48. PubMed ID: 26450777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson's Disease.
    Tang T; Li Y; Jiao Q; Du X; Jiang H
    Neurosci Bull; 2017 Oct; 33(5):568-575. PubMed ID: 28337696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophic factors for the treatment of Parkinson's disease.
    Sullivan AM; Toulouse A
    Cytokine Growth Factor Rev; 2011 Jun; 22(3):157-65. PubMed ID: 21689963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategies for neurodegenerative disorders: emerging clues from Parkinson's disease.
    Bjarkam CR; Sørensen JC
    Biol Psychiatry; 2004 Aug; 56(4):213-6. PubMed ID: 15312807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: A systematic review and meta-analysis.
    Hegarty SV; Lee DJ; O'Keeffe GW; Sullivan AM
    Parkinsonism Relat Disord; 2017 May; 38():19-25. PubMed ID: 28215730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophic factors for the treatment of Parkinson's disease.
    Chiocco MJ; Harvey BK; Wang Y; Hoffer BJ
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S321-8. PubMed ID: 18267258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does neurotrophic factor benefit to PD therapy via co-function with ubiquitin-proteasome system?
    Niu C; Zhang J; Mei J; Fu X
    Med Hypotheses; 2011 Apr; 76(4):589-92. PubMed ID: 21288653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease.
    Kordower JH
    Ann Neurol; 2003; 53 Suppl 3():S120-32; discussion S132-4. PubMed ID: 12666104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel CDNF/MANF family of neurotrophic factors.
    Lindholm P; Saarma M
    Dev Neurobiol; 2010 Apr; 70(5):360-71. PubMed ID: 20186704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review.
    Staudt MD; Di Sebastiano AR; Xu H; Jog M; Schmid S; Foster P; Hebb MO
    Gerontology; 2016; 62(3):371-80. PubMed ID: 26330171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDNF Protein Therapy in Parkinson's Disease.
    Huttunen HJ; Saarma M
    Cell Transplant; 2019 Apr; 28(4):349-366. PubMed ID: 30947516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.
    Zhao Q; Gao J; Li W; Cai D
    Brain Res; 2010 Jul; 1346():224-36. PubMed ID: 20478277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury.
    Abe K
    J Cereb Blood Flow Metab; 2000 Oct; 20(10):1393-408. PubMed ID: 11043902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (I)].
    Mínguez-Castellanos A; Escamilla-Sevilla F
    Rev Neurol; 2005 Nov 16-30; 41(10):604-14. PubMed ID: 16288424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (II)].
    Mínguez-Castellanos A; Escamilla-Sevilla F
    Rev Neurol; 2005 Dec 1-15; 41(11):684-93. PubMed ID: 16317638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.